| Disaggregation of Revenue |
The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 29, 2025 | | Three Months Ended March 30, 2024 | Business (in millions) | United States | International | Total | | United States | International | Total | | Diagnostics: | | | | | | | | | Cytology & Perinatal | $ | 71.1 | | $ | 47.4 | | $ | 118.5 | | | $ | 70.7 | | $ | 49.8 | | $ | 120.5 | | | Molecular Diagnostics | 258.7 | | 67.3 | | 326.0 | | | 255.4 | | 67.3 | | 322.7 | | | Blood Screening | 9.1 | | — | | 9.1 | | | 6.9 | | — | | 6.9 | | | Total | $ | 338.9 | | $ | 114.7 | | $ | 453.6 | | | $ | 333.0 | | $ | 117.1 | | $ | 450.1 | | | | | | | | | | | | Breast Health: | | | | | | | | | Breast Imaging | $ | 209.4 | | $ | 62.5 | | $ | 271.9 | | | $ | 234.9 | | $ | 71.8 | | $ | 306.7 | | | Interventional Breast Solutions | 62.0 | | 22.3 | | 84.3 | | | 60.4 | | 17.5 | | 77.9 | | | | | | | | | | | | Total | $ | 271.4 | | $ | 84.8 | | $ | 356.2 | | | $ | 295.3 | | $ | 89.3 | | $ | 384.6 | | | | | | | | | | | | GYN Surgical | $ | 117.0 | | $ | 45.5 | | $ | 162.5 | | | $ | 115.6 | | $ | 40.4 | | $ | 156.0 | | | | | | | | | | | Skeletal Health | $ | 17.6 | | $ | 15.4 | | $ | 33.0 | | | $ | 15.5 | | $ | 11.6 | | $ | 27.1 | | | | $ | 744.9 | | $ | 260.4 | | $ | 1,005.3 | | | $ | 759.4 | | $ | 258.4 | | $ | 1,017.8 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended March 29, 2025 | | Six Months Ended March 30, 2024 | Business (in millions) | United States | International | Total | | United States | International | Total | | Diagnostics: | | | | | | | | | Cytology & Perinatal | $ | 147.1 | | $ | 96.9 | | $ | 244.0 | | | $ | 140.5 | | $ | 100.0 | | $ | 240.5 | | | Molecular Diagnostics | 521.2 | | 145.7 | | 666.9 | | | 502.9 | | 139.6 | | 642.5 | | | Blood Screening | 13.3 | | — | | 13.3 | | | 14.9 | | — | | 14.9 | | | Total | $ | 681.6 | | $ | 242.6 | | $ | 924.2 | | | $ | 658.3 | | $ | 239.6 | | $ | 897.9 | | | | | | | | | | | | Breast Health: | | | | | | | | | Breast Imaging | $ | 425.1 | | $ | 128.3 | | $ | 553.4 | | | $ | 463.3 | | $ | 144.8 | | $ | 608.1 | | | Interventional Breast Solutions | 128.4 | | 43.4 | | 171.8 | | | 121.5 | | 32.7 | | 154.2 | | | | | | | | | | | | Total | $ | 553.5 | | $ | 171.7 | | $ | 725.2 | | | $ | 584.8 | | $ | 177.5 | | $ | 762.3 | | | | | | | | | | | | GYN Surgical | $ | 238.9 | | $ | 90.0 | | $ | 328.9 | | | $ | 240.8 | | $ | 77.4 | | $ | 318.2 | | | | | | | | | | | Skeletal Health | $ | 28.8 | | $ | 20.0 | | $ | 48.8 | | | $ | 29.2 | | $ | 23.3 | | $ | 52.5 | | | | $ | 1,502.8 | | $ | 524.3 | | $ | 2,027.1 | | | $ | 1,513.1 | | $ | 517.8 | | $ | 2,030.9 | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | Geographic Regions (in millions) | | March 29, 2025 | March 30, 2024 | | March 29, 2025 | March 30, 2024 | | United States | | $ | 744.9 | | $ | 759.4 | | | $ | 1,502.8 | | $ | 1,513.1 | | | Europe | | 146.5 | | 137.0 | | | 295.4 | | 279.8 | | | Asia-Pacific | | 59.7 | | 64.4 | | | 119.5 | | 128.2 | | | Rest of World | | 54.2 | | 57.0 | | | 109.4 | | 109.8 | | | | $ | 1,005.3 | | $ | 1,017.8 | | | $ | 2,027.1 | | $ | 2,030.9 | |
The following table provides revenue recognized by source:
| | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | Revenue by type (in millions) | | March 29, 2025 | March 30, 2024 | | March 29, 2025 | March 30, 2024 | | Disposables | | $ | 636.9 | | $ | 618.9 | | | $ | 1,300.6 | | $ | 1,247.8 | | | Capital equipment, components and software | | 155.8 | | 209.1 | | | 310.0 | | 408.2 | | | Service | | 207.9 | | 185.0 | | | 406.5 | | 363.8 | | | Other | | 4.7 | | 4.8 | | | 10.0 | | 11.1 | | | | $ | 1,005.3 | | $ | 1,017.8 | | | $ | 2,027.1 | | $ | 2,030.9 | |
|